Trial intelligence / Profile preview

FMT in Chronic Pouchitis

NCT03378921Phase 2Completed

Sponsor
Helsinki University Hospital
Start
Feb 2018
Primary completion
Sep 2019
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

A Phase 2 trial of allogeneic fecal microbiota in pouchitis, sponsored by Helsinki University Hospital. Started Feb 2018; status: completed.

02

Drugs

allogeneic fecal microbiota
03

Conditions

pouchitis

Beyond the preview

Go deeper on NCT03378921.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03378921.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call